TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 116.57%1.21B | ---- | -41.80%-7.33B | ---- | 28.28%-5.17B | ---- | -242.13%-7.2B | ---- | -19.00%5.07B |
Profit adjustment | ||||||||||
Impairment and provisions: | ---- | -9.27%-64.31M | ---- | -131.82%-58.86M | ---- | -22.14%184.97M | ---- | 433.51%237.56M | ---- | 92.43%44.53M |
-Other impairments and provisions | ---- | -9.27%-64.31M | ---- | -131.82%-58.86M | ---- | -22.14%184.97M | ---- | 433.51%237.56M | ---- | 92.43%44.53M |
Revaluation surplus: | ---- | ---388.76M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Derivative financial instruments fair value (increase) | ---- | ---388.76M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 2.86%2.37B | ---- | -12.07%2.31B | ---- | -9.96%2.62B | ---- | -0.24%2.92B | ---- | 7.19%2.92B |
-Depreciation | ---- | 2.86%2.37B | ---- | -12.07%2.31B | ---- | -2.45%2.62B | ---- | -0.09%2.69B | ---- | 2.37%2.69B |
Financial expense | ---- | 30.13%3.34B | ---- | 9.46%2.56B | ---- | 19.93%2.34B | ---- | 31.35%1.95B | ---- | -0.62%1.49B |
Exchange Loss (gain) | ---- | 309.05%90.13M | ---- | -124.54%-43.12M | ---- | 279.66%175.68M | ---- | 14.39%-97.78M | ---- | -384.63%-114.23M |
Special items | ---- | -151.75%-204.7M | ---- | 21.04%395.58M | ---- | 8.90%326.81M | ---- | 265.45%300.1M | ---- | -50.26%82.12M |
Operating profit before the change of operating capital | ---- | 393.99%6.36B | ---- | -543.80%-2.16B | ---- | 125.68%487.16M | ---- | -119.99%-1.9B | ---- | -11.37%9.49B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -137.02%-5.86M | ---- | 269.21%15.83M | ---- | -115.65%-9.36M | ---- | 275.98%59.8M | ---- | -278.66%-33.98M |
Accounts receivable (increase)decrease | ---- | -389.35%-476.69M | ---- | -54.93%164.75M | ---- | 94.53%365.56M | ---- | 146.59%187.92M | ---- | 40.33%-403.35M |
Accounts payable increase (decrease) | ---- | 850.00%1.01B | ---- | 93.45%-134.42M | ---- | 1.82%-2.05B | ---- | 10.16%-2.09B | ---- | -510.39%-2.33B |
prepayments (increase)decrease | ---- | -537.38%-62.89M | ---- | 63.86%14.38M | ---- | -79.78%8.78M | ---- | 17.12%43.39M | ---- | -36.03%37.05M |
Cash from business operations | ---- | 424.47%6.82B | ---- | -75.13%-2.1B | ---- | 67.53%-1.2B | ---- | -154.64%-3.7B | ---- | -30.47%6.76B |
Other taxs | ---- | 65.68%-6.35M | ---- | -48.90%-18.5M | ---- | 0.00%-12.43M | ---- | 0.00%-12.43M | ---- | 0.00%-12.43M |
Special items of business | 25.48%3.8B | ---- | 294.51%3.03B | ---- | -75.70%-1.56B | ---- | 38.63%-887.27M | ---- | -134.42%-1.45B | ---- |
Net cash from operations | 25.48%3.8B | 421.34%6.81B | 294.51%3.03B | -74.86%-2.12B | -75.70%-1.56B | 67.31%-1.21B | 38.63%-887.27M | -154.93%-3.71B | -134.42%-1.45B | -30.51%6.75B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 45.80%203.95M | 439.55%434.15M | 1,017.21%139.89M | 349.44%80.46M | 10.99%12.52M | -80.08%17.9M | -83.81%11.28M | 7.93%89.87M | 43.13%69.68M | -7.33%83.27M |
Restricted cash (increase) decrease | -100.07%-205K | 129.98%291.05M | 192,707.28%291.14M | -647,075.33%-970.76M | 200.67%151K | -40.19%-150K | -40.19%-150K | 98.70%-107K | ---107K | ---8.21M |
Sale of fixed assets | ---- | 874.79%2.36M | 925.65%2.36M | 16.91%242K | 48.39%230K | 263.16%207K | 171.93%155K | -92.32%57K | 470.00%57K | -91.45%742K |
Purchase of fixed assets | -251.04%-616.02M | -104.86%-714.3M | 24.00%-175.49M | 26.75%-348.68M | -34.38%-230.92M | 36.46%-476.02M | 63.57%-171.84M | 54.33%-749.15M | 34.13%-471.7M | -37.97%-1.64B |
Recovery of cash from investments | --1.57B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---- | -11,482.93%-5.42B | -2,307.37%-1.13B | ---46.81M | ---46.81M | ---- | ---- | ---- | ---- | ---- |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | -74.93%4.15M | ---- | -20.63%16.56M | --16.56M | --20.87M |
Net cash from investment operations | 232.75%1.15B | -320.77%-5.41B | -228.17%-869.09M | -183.22%-1.29B | -64.95%-264.83M | 29.38%-453.91M | 58.35%-160.55M | 58.36%-642.77M | 42.24%-385.5M | -41.57%-1.54B |
Net cash before financing | 129.23%4.96B | 141.20%1.4B | 218.61%2.16B | -104.38%-3.41B | -74.05%-1.82B | 61.70%-1.67B | 42.78%-1.05B | -183.55%-4.35B | -151.84%-1.83B | -39.62%5.21B |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 183.64%4.71B | --4.71B | -84.08%1.66B | ---- | -58.93%10.43B | -96.61%388.64M | 73.33%25.39B | 1,853.26%11.45B | 199.54%14.65B |
Refund | ---2.44B | ---- | ---- | ---- | ---- | 8.30%-13.4B | 7.47%-3.6B | -62.43%-14.61B | 17.06%-3.89B | ---9B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --546K | --546K | ---- |
Interest paid - financing | -5.99%-1.47B | -18.88%-2.91B | -20.68%-1.39B | -7.87%-2.45B | 0.20%-1.15B | -49.55%-2.27B | -41.56%-1.15B | -11.23%-1.52B | -17.86%-814.32M | -2.84%-1.37B |
Dividends paid - financing | -133,541.64%-391.57M | 90.85%-293K | 89.84%-293K | 20.43%-3.2M | 4.28%-2.88M | 52.35%-4.02M | 35.12%-3.01M | 99.82%-8.44M | 99.80%-4.64M | 40.00%-4.67B |
Other items of the financing business | 42.85%-128.42M | -1,091.76%-267.17M | -916.78%-224.71M | 90.84%-22.42M | -80.59%-22.1M | -1,981.28%-244.82M | 69.77%-12.24M | 89.32%-11.76M | -485.18%-40.48M | 7.77%-110.17M |
Net cash from financing operations | -245.14%-4.45B | 272.74%1.49B | 354.71%3.07B | 84.54%-860.42M | 72.81%-1.2B | -160.96%-5.57B | -166.62%-4.43B | 1,569.33%9.13B | 192.31%6.65B | 85.67%-621.27M |
Effect of rate | -143.77%-7.5M | -149.26%-12.19M | -67.68%17.12M | -61.55%24.74M | 184.29%52.98M | 290.27%64.35M | 139.47%18.64M | -34.10%-33.82M | -996.84%-47.22M | -452.15%-25.22M |
Net Cash | -90.34%505.12M | 167.73%2.89B | 272.75%5.23B | 41.01%-4.27B | 44.72%-3.03B | -251.36%-7.23B | -213.68%-5.48B | 4.17%4.78B | 231.23%4.82B | 6.87%4.59B |
Begining period cash | 38.76%10.3B | -36.36%7.42B | -36.36%7.42B | -38.06%11.66B | -38.06%11.66B | 33.67%18.83B | 33.67%18.83B | 47.88%14.09B | 47.88%14.09B | 81.81%9.53B |
Cash at the end | -14.79%10.8B | 38.76%10.3B | 45.84%12.67B | -36.36%7.42B | -35.02%8.69B | -38.06%11.66B | -29.10%13.37B | 33.67%18.83B | 222.40%18.86B | 47.88%14.09B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.